Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open-Label, Expanded Access Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

NCT01160250 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01160250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open-Label, Expanded Access Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Lead sponsor
Genentech, Inc.
Phase
Expanded access
Overall status
Approved for marketing
Start date
July 31, 2010
Completion date
April 30, 2012
Enrollment
Not reported
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma